University of Cambridge > > Cambridge Oncology Seminar Series > Cellular responses to DNA damage: translating molecular insights towards new cancer therapies

Cellular responses to DNA damage: translating molecular insights towards new cancer therapies

Add to your list(s) Download to your calendar using vCal

  • UserProf Steve Jackson, Head of Cancer Research UK Laboratories The Gurdon Institute, Cambridge
  • ClockTuesday 27 November 2012, 12:00-13:00
  • HouseCRI Lecture Theatre.

If you have a question about this talk, please contact Mala Jayasundera.

Inherited or acquired defects in detecting, signalling or repairing DNA damage are associated with various human pathologies, including immunodeficiencies, neurodegenerative diseases and cancer(1). Work in my laboratory aims to decipher the mechanisms by which cells detect DNA damage, signal its presence and mediate its repair(2). Much of our work focuses on DNA double-strand breaks (DSBs) that are generated by ionizing radiation and radiomimetic chemicals, and which also arise when the DNA replication apparatus encounters various forms of DNA damage. In this talk, I will summarize how our recent work has helped to establish how protein complexes assemble and disassemble on chromatin at sites of DNA damage and how these complexes promote DNA repair and DNA -damage signalling. I will also explain how our increasing knowledge of cellular DNA -damage responses is providing exciting opportunities for developing novel treatments for cancer(3). Finally, I will describe how the Cambridge-based company MISSION Therapeutics ( plans to exploit these opportunities to produce new, more effective anti-cancer medicines.

References 1. Jackson, S.P. and Bartek, J. (2009). The DNA -damage response in human biology and disease. Nature 461, 1071-1078. 2. Polo SE and Jackson SP. (2011). Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications. Genes Dev. 25, 409-433. 3. Jackson, SP. (2009). The DNA -damage response: new molecular insights and new approaches to cancer therapy. Biochem. Soc. Trans. 37, 383-394

This talk is part of the Cambridge Oncology Seminar Series series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2023, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity